ESC 365 - Preoperative dual antiplatelet therapy and early outcomes in patients undergoing coronary artery bypass grafting

ESC Premium Access

Preoperative dual antiplatelet therapy and early outcomes in patients undergoing coronary artery bypass grafting

Session: Factors affecting prognosis of CABG patients

Topic: Coronary Arteries

Speaker: Doctor J. Qu (Beijing, CN)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Jianyu Qu

Fuwai Hospital, CAMS and PUMC, Beijing (China)

0 follower

4 more presentations in this session

Effect of ticagrelor plus aspirin, ticagrelor alone, or aspirin alone on vein-graft patency 1 year after coronary artery bypass grafting with or without diabetes: a post-hoc analysis of the DACAB tria

Speaker: Doctor Y. Zhu (Shanghai, CN)

"New-onset atrial fibrillation efter cardiac surgery is associated with increased long-term morbidity and mortality": a population-based study from the SWEDEHEART-registry.

Speaker: Doctor A. Taha (Gothenburg, SE)

The randomised study of epicardial application of hydrogel with amiodarone for prevention of postoperative atrial fibrillation in patients after coronary artery bypass grafting

Speaker: Doctor T. Kanametov (Moscow, RU)

Limited impact of concomitant coronary artery by-pass grafting on long-term outcomes after surgical aortic valve replacement: a nationwide propensity matched study

Speaker: Doctor V. Kyto (Turku, FI)

Access the full session

Factors affecting prognosis of CABG patients

Speakers: Doctor J. Qu, Doctor Y. Zhu, Doctor A. Taha, Doctor T. Kanametov, Doctor V. Kyto

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources